指南与共识心脏核医学肿瘤 PET/CT

新指南联合专用FDG PET/CT诊断的孤立性心脏结节病临床特征与预后

Clinical features and prognosis of isolated cardiac sarcoidosis diagnosed using new guidelines with dedicated FDG PET/CT.
指南 / 共识 · J Nucl Cardiol · 2022-07-08

该研究回顾性分析82例疑似心脏结节病(CS)患者,其中系统性结节病累及心脏(sCS)55例、孤立性心脏结节病(iCS)27例,比较两组FDG PET/CT表现及不良心脏事件。iCS组靶本底比显著低于sCS组(P=0.0010),无事件生存率显著低于sCS组(log-rank检验P<0.0001),iCS为不良事件的独立预后因素(风险比3.82,P=0.0059)。

要点

  • iCS组靶本底比显著低于sCS组(P=0.0010)。
  • iCS组无事件生存率显著低于sCS组(log-rank检验P<0.0001)。
  • iCS为不良心脏事件的独立预后因素(风险比3.82,P=0.0059)。

核心结论

  • iCS是CS患者不良心脏事件的独立预后因素。
  • 基于FDG PET/CT和新指南对iCS进行临床诊断可能具有重要意义。

研究设计与样本

  • 回顾性分析2016年首次提出iCS诊断指南后,连续306例疑似CS并接受专用准备方案FDG PET/CT检查患者的临床和影像数据。
  • 最终纳入82例患者,其中系统性结节病累及心脏(sCS)55例、孤立性心脏结节病(iCS)27例。
  • 比较两组FDG PET/CT表现,并分析CS类型与不良心脏事件发生率的关系。

主要发现

  • iCS组靶本底比显著低于sCS组(P=0.0010)。
  • iCS组无事件生存率显著低于sCS组(log-rank检验P<0.0001)。
  • iCS为不良心脏事件的独立预后因素(风险比3.82,P=0.0059)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Diagnostic guidelines for isolated cardiac sarcoidosis (iCS) were first proposed in 2016, but there are few reports on the imaging and prognosis of iCS. This study aimed to evaluate the use of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) imaging in predicting iCS prognosis. METHODS AND RESULTS: We retrospectively reviewed the clinical and imaging data of 306 consecutive patients with suspected CS who underwent FDG PET/CT with a dedicated preparation protocol and included 82 patients (55 with systemic sarcoidosis including cardiac involvement [sCS], 27 with iCS) in the study. We compared the FDG PET/CT findings between the two groups. We examined the relationship between the CS type and the rate of adverse cardiac events. The iCS group had a significantly lower target-to-background ratio than the sCS group (P = 0.0010). The event-free survival rate was significantly lower in the iCS group than the sCS group (log-rank test, P < 0.0001). iCS was identified as an independent prognostic factor for adverse events (hazard ratio 3.82, P = 0.0059). CONCLUSION: iCS was an independent prognostic factor for adverse cardiac events in patients with CS. The clinical diagnosis of iCS based on FDG PET/CT and new guidelines may be important.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Okada T, Kawaguchi N, Miyagawa M, et al. Clinical features and prognosis of isolated cardiac sarcoidosis diagnosed using new guidelines with dedicated FDG PET/CT. J Nucl Cardiol. 2022. PMID: 35804283. doi:10.1007/s12350-022-03034-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。